Back to search results

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Lymphocytic Leukemia (ALL) · Acute Myeloid Leukemia (AML) · Acute Leukemia · Myelodysplastic Syndrome(MDS) · Myeloproliferative Neoplasm (MPN)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UMPC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Amy Rogers, RN, BSN) · rodgera@upmc.edu · 412-623-4036
    Contact: Study coordinator (Linda Elias, RN, BSN) · eliaslj@upmc.edu · 412-623-6037
    Contact: Principal Investigator (Sawa Ito, MD)
Study leads

  • Sawa M Ito, MD

    Principal Investigator

    UPMC Hillman Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)